Tag Archives: malaria vaccine development program

Leidos (NYSE: LDOS) has been awarded a potential five-year, $23.7 million contract to support the U.S. Agency for International Development‘s efforts to research and develop a vaccine against malaria. The company said Monday it will provide scientific and management services for USAID’s Malaria Vaccine Development Program under the cost-plus-fixed-fee contract. Jerry …

Read More »